WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
33.06
+0.40 (1.22%)
May 11, 2026, 4:08 PM HKT

WuXi Biologics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
135,140129,96072,100124,993252,882390,943
Market Cap Growth
57.48%80.25%-42.32%-50.57%-35.32%-6.90%
Enterprise Value
127,531126,32271,052122,776247,673380,146
Last Close Price
32.6631.4417.5629.6059.8592.55
PE Ratio
25.2923.7920.1933.3750.6193.99
Forward PE
19.7621.6417.0922.7137.4177.91
PS Ratio
5.575.363.636.6614.6530.95
PB Ratio
2.292.201.492.586.189.74
P/TBV Ratio
2.682.581.702.966.7910.56
P/FCF Ratio
45.7343.9752.62182.37--
P/OCF Ratio
19.1518.4212.9924.3140.3792.82
PEG Ratio
1.231.131.991.391.021.99
EV/Sales Ratio
5.265.213.586.5414.3530.10
EV/EBITDA Ratio
14.1614.3311.4222.6143.2285.50
EV/EBIT Ratio
17.2417.0814.5628.3450.3697.69
EV/FCF Ratio
43.1542.7451.85179.13--
Debt / Equity Ratio
0.060.060.110.100.120.13
Debt / EBITDA Ratio
0.380.380.820.890.861.18
Debt / FCF Ratio
1.171.173.847.33--
Net Debt / Equity Ratio
-0.24-0.24-0.13-0.15-0.12-0.21
Net Debt / EBITDA Ratio
-1.59-1.59-0.99-1.36-0.85-1.89
Net Debt / FCF Ratio
-4.75-4.75-4.48-10.7413.142.22
Asset Turnover
0.360.360.330.320.330.28
Inventory Turnover
8.118.116.715.044.313.94
Quick Ratio
2.972.971.982.351.561.85
Current Ratio
3.393.392.732.781.982.37
Return on Equity (ROE)
11.64%11.64%8.82%8.90%13.20%13.09%
Return on Assets (ROA)
6.88%6.88%5.05%4.63%5.81%5.43%
Return on Invested Capital (ROIC)
12.99%13.11%9.71%9.72%12.78%13.38%
Return on Capital Employed (ROCE)
12.00%12.00%9.50%8.00%10.80%8.90%
Earnings Yield
4.04%4.20%4.95%3.00%1.98%1.06%
FCF Yield
2.19%2.27%1.90%0.55%-0.15%-0.97%
Buyback Yield / Dilution
1.22%1.22%2.80%0.62%1.04%-5.05%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.